Primecap Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$353M Sell
3,907,150
-92,260
-2% -$8.47M 0.28% 78
2025
Q4
$360M Sell
3,999,410
-251,220
-6% -$23.8M 0.27% 77
2025
Q3
$419M Sell
4,250,630
-460,200
-10% -$45.6M 0.32% 64
2025
Q2
$430M Buy
4,710,830
+27,860
+0.6% +$2.69M 0.34% 64
2025
Q1
$530M Sell
4,682,970
-114,180
-2% -$12.2M 0.44% 55
2024
Q4
$507M Sell
4,797,150
-174,230
-4% -$18.7M 0.39% 61
2024
Q3
$537M Sell
4,971,380
-83,210
-2% -$9.08M 0.39% 58
2024
Q2
$549M Sell
5,054,590
-8,360
-0.2% -$986K 0.4% 58
2024
Q1
$668M Sell
5,062,950
-23,628
-0.5% -$2.95M 0.5% 49
2023
Q4
$619M Buy
5,086,578
+484,151
+11% +$54M 0.49% 50
2023
Q3
$516M Sell
4,602,427
-260,365
-5% -$33.1M 0.44% 54
2023
Q2
$708M Sell
4,862,792
-72,120
-1% -$9.8M 0.59% 47
2023
Q1
$638M Buy
4,934,912
+103,790
+2% +$13M 0.56% 47
2022
Q4
$616M Sell
4,831,122
-76,415
-2% -$8.87M 0.56% 49
2022
Q3
$513M Sell
4,907,537
-775
-0% -$85K 0.5% 55
2022
Q2
$516M Sell
4,908,312
-23,110
-0.5% -$2.74M 0.46% 61
2022
Q1
$631M Buy
4,931,422
+740,743
+18% +$89.3M 0.48% 62
2021
Q4
$517M Buy
4,190,679
+196,432
+5% +$25.7M 0.36% 69
2021
Q3
$568M Buy
3,994,247
+285,742
+8% +$42M 0.4% 69
2021
Q2
$579M Buy
3,708,505
+95,461
+3% +$15.5M 0.39% 70
2021
Q1
$562M Buy
3,613,044
+25,348
+0.7% +$3.93M 0.39% 66
2020
Q4
$537M Sell
3,587,696
-190,406
-5% -$26.9M 0.4% 67
2020
Q3
$499M Buy
3,778,102
+64,643
+2% +$8.44M 0.41% 62
2020
Q2
$430M Buy
3,713,459
+188,758
+5% +$21.8M 0.37% 67
2020
Q1
$346M Buy
3,524,701
+503,793
+17% +$66M 0.34% 68
2019
Q4
$439M Sell
3,020,908
-8,446
-0.3% -$1.17M 0.32% 74
2019
Q3
$404M Buy
3,029,354
+398,610
+15% +$51.5M 0.32% 77
2019
Q2
$301M Buy
2,630,744
+93,112
+4% +$10.9M 0.22% 102
2019
Q1
$315M Buy
2,537,632
+576,151
+29% +$65.5M 0.23% 97
2018
Q4
$198M Buy
1,961,481
+196,133
+11% +$22.1M 0.16% 112
2018
Q3
$225M Buy
1,765,348
+441,160
+33% +$52.5M 0.15% 117
2018
Q2
$143M Buy
1,324,188
+197,328
+18% +$21.5M 0.11% 131
2018
Q1
$119M Buy
1,126,860
+232,717
+26% +$27M 0.09% 139
2017
Q4
$105M Buy
894,143
+213,210
+31% +$24.1M 0.08% 142
2017
Q3
$77.4M Sell
680,933
-4,635
-0.7% -$535K 0.06% 154
2017
Q2
$85.5M Buy
685,568
+228,454
+50% +$27.1M 0.07% 151
2017
Q1
$54.2M Sell
457,114
-6,386
-1% -$724K 0.05% 160
2016
Q4
$46.4M Sell
463,500
-2,369
-0.5% -$254K 0.05% 165
2016
Q3
$58.8M Sell
465,869
-13,287
-3% -$1.64M 0.06% 155
2016
Q2
$56M Sell
479,156
-64,993
-12% -$7.36M 0.06% 155
2016
Q1
$56.3M Buy
544,149
+824
+0.2% +$79.7K 0.06% 159
2015
Q4
$54.1M Sell
543,325
-2,884
-0.5% -$282K 0.06% 163
2015
Q3
$49.8M Sell
546,209
-59,122
-10% -$5.93M 0.06% 168
2015
Q2
$64.2M Buy
605,331
+44,698
+8% +$4.95M 0.06% 164
2015
Q1
$64M Buy
560,633
+100,528
+22% +$11.5M 0.06% 162
2014
Q4
$50.7M Sell
460,105
-2,575
-0.6% -$271K 0.05% 169
2014
Q3
$45.2M Sell
462,680
-923
-0.2% -$90.8K 0.05% 170
2014
Q2
$46.7M Sell
463,603
-7,313
-2% -$714K 0.05% 160
2014
Q1
$43.2M Sell
470,916
-103
-0% -$9.49K 0.05% 161
2013
Q4
$42.6M Sell
471,019
-6,489
-1% -$562K 0.05% 164
2013
Q3
$38.1M Sell
477,508
-14,111
-3% -$1.11M 0.05% 163
2013
Q2
$35.8M Buy
+491,619
New +$36.8M 0.05% 156

Other funds holding ZBH

Primecap Management's ZBH Position: Q1 2026 in Review

Primecap Management reduced its Zimmer Biomet (ZBH) stake by 2.3% in Q1 2026, selling an estimated $8.47M and leaving 3,907,150 shares worth $353M. The position accounts for 0.28% of the portfolio, ranked #78.

Primecap Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $708M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Primecap Management held 3,907,150 shares of Zimmer Biomet worth $353M as of Q1 2026.
  • Primecap Management sold 92,260 Zimmer Biomet shares in Q1 2026, an estimated $8.47M.
  • Zimmer Biomet made up 0.28% of Primecap Management's portfolio in Q1 2026, its #78 holding.
  • Primecap Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Primecap Management's Zimmer Biomet position peaked at $708M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Primecap Management's 13F filing for Q1 2026, filed 11 May 2026.